ArticleCerebellum (London, England)2025
Single-Session Feasibility of Cough Skill Training in Cerebellar Ataxia.
Article in Cerebellum (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Cerebellar ataxia (CA) is a heterogenous neurodegenerative disease affecting multiple neural structures. Individuals with CA exhibit difficulty coordinating voluntary movements and have a high prevalence of cough (dystussia) and swallowing (dysphagia) dysfunction. Although skill-based approaches to cough rehabilitation are efficacious for other neurogenerative diseases, the feasibility in CA remains unexplored. Seven people with genetically confirmed CA (6 female, 1 male) completed baseline voluntary cough assessments, followed by a single session of cough skill training (CST). Participants were instructed to cough with sufficient intensity to hit a target line set 25% above baseline maximum peak expiratory flow rate (PEFR). Metrics of feasibility included the percentage of trials completed, no adverse events, and duration of the treatment session. Bayesian multilevel models examined changes in three cough airflow outcomes: PEFR, cough expired volume (CEV), and cough inspired volume (CIV). All participants completed every trial of CST in less than one hour without any adverse events. PEFR improved by 0.77 L/s (95% CI: 0.37, 1.09) on single and 0.49 L/s (95% CI: 0.17, 0.76) on sequential voluntary cough. CEV increased by 0.36 L (95% CI: 0.11, 0.76) on single and 0.19 L (95% CI: 0.02, 0.46) on sequential voluntary cough. CIV showed no significant change. Individuals with CA demonstrated the ability to upregulate voluntary cough during a single session of CST within a manageable amount of time. These findings highlight the potential for modifiable cough outcomes in this population and support further research on the efficacy of CST in CA.
Indexed as
Identifiers
40643748What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.